VHsquared (United Kingdom)

Recent papers from VHsquared (United Kingdom)

1. Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel diseaseENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2021
2. Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis PatientsScientific Reports · 2019
3. Oral delivery of the anti-tumor necrosis factor α domain antibody, V565, results in high intestinal and fecal concentrations with minimal systemic exposure in cynomolgus monkeysDrug Development and Industrial Pharmacy · 2018
4. Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel DiseaseScientific Reports · 2018
5. A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients with Moderate to Severe Atopic DermatitisSKIN The Journal of Cutaneous Medicine · 2018
6. Interleukins and their signaling pathways in the Reactome biological pathway databaseJournal of Allergy and Clinical Immunology · 2018